Japanese encephalitis is a serious infection that can be transmitted by mosquitoes with a mortality rate of 25 to 30%.
Every year approximately 35,000 to 50,000 people are infected with Japanese encephalitis viral infection every year.
Unfortunately, the drugs used for Japanese encephalitis are not always effective.
A case-study reported that a tincture of pokeweed provided beneficial effects for a patient with Japanese Encephalitis Virus infection in an intensive care unit patient.
The plant pokeweed (Phytolacca Americana L.) is reported to have multiple medicinal properties including inflammation, arthritis, and viral fever infections in traditional medicines.
Here are the details of this case report
-A 42-year-old male patient with JEV infection failed to respond to conventional therapy.
-The patient was administered pokeweed tincture orally, two drops three times daily along with conventional therapy.
-The product used was (Phytolacca-mother tincture, Dr. Reckeweg & Co, Bensheim, Germany).
-The patient was discharged after 2 months of treatment.
-The patient showed partial remission of Japanese Encephalitis infection infection with few neurological sequelae.
How might pokeweed work for Japanese Encephalitis viral infection?
A protein found in pokeweed inhibits viral RNA synthesis.
Here are the comments by the authors
For the first time, this case presentation shows therapeutic management of JEV encephalitis with phytolacca-mother tincture. Although its effectiveness as a standalone therapy against JEV encephalitis is not established, it can be considered as a complementary therapy to the conventional treatment management.
Reference
Chaundhury HC et al. Case report on recovery from Japanese encephalitis virus infection by complementary use of phytolacca-mother tincture and in silico analysis. Volume 14, December 2018, Pages 22-28
Categories: Clinical Trials, Infection, Plant Medicine